We have got an intentionally created, modified pandemic that there is no doubt about being gain of function, (just Like Coof), being inflicted into the world population purely for the purpose of depopulation and control.
There aren't THAT many labs that can do this. They all need to be stopped. Anyone this malevolent needs to be destroyed.
https://www.pnas.org/doi/10.1073/pnas.0800589105.
From 2008:
Monkeypox virus (MPV) is a virulent human pathogen that has gained increased attention because of its potential use as a bioterrorism agent and inadvertent introduction into North America in 2003.
Our own governments are intentionally using bioweapons against its civilians. WHO be damned, they are in on it.
Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge
Lauren A. Hirao, Ruxandra Draghia-Akli, Jonathan T. Prigge, Maria Yang, Abhishek Satishchandran, Ling Wu, Erika Hammarlund, Amir S. Khan, Tahar Babas, Lowrey Rhodes
... Show more
Author Notes
The Journal of Infectious Diseases, Volume 203, Issue 1, 1 January 2011, Pages 95–102,
https://doi.org/10.1093/infdis/jiq017
Published:
01 January 2011
Article historyAbstract
The threat of a smallpox-based bioterrorist event or a human monkeypox outbreak has heightened the importance of new, safe vaccine approaches for these pathogens to complement older poxviral vaccine platforms. As poxviruses are large, complex viruses, they present technological challenges for simple recombinant vaccine development where a multicomponent mixtures of vaccine antigens are likely important in protection. We report that a synthetic, multivalent, highly concentrated, DNA vaccine delivered by a minimally invasive, novel skin electroporation microarray can drive polyvalent immunity in macaques, and offers protection from a highly pathogenic monkeypox challenge. Such a diverse, high-titer antibody response produced against 8 different DNA-encoded antigens delivered simultaneously in microvolumes has not been previously described. These studies represent a significant improvement in the efficiency of the DNA vaccine platform, resulting in immune responses that mimic live viral infections, and would likely have relevance for vaccine design against complex human and animal pathogens.